Contact

New Publication on TAA PepMixes™ Confirms Melan-A and NY-ESO-1 as Targets for Immunotherapy

 New Publication on TAA PepMixes™ Confirms Melan-A and NY-ESO-1 as Targets for Immunotherapy:

"Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis."
(June, 2012)

=> read more

Stay in touch and be the first to receive the latest news!